Figure 3
The suspect Maloxine® sample, having failed semi-quantitative thin-layer chromatography. The manufacturer is wrong to allege that it is the “only single dose treatment of malaria”.
Figure 3 | Malaria Journal
The suspect Maloxine® sample, having failed semi-quantitative thin-layer chromatography. The manufacturer is wrong to allege that it is the “only single dose treatment of malaria”.